“Prognostic Value And Clinical Impact Of EBV And PDL1 Expression In Classical Hodgkin Lymphoma”, Journal of Pharmaceutical Negative Results, pp. 3461–3472, Feb. 2023, doi: 10.47750/pnr.2023.14.02.406.